Format

Send to

Choose Destination
Mol Syst Biol. 2012;8:601. doi: 10.1038/msb.2012.32.

Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS.

Author information

1
Laboratory of Molecular Tumour Pathology, Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Abstract

RAS mutations are highly relevant for progression and therapy response of human tumours, but the genetic network that ultimately executes the oncogenic effects is poorly understood. Here, we used a reverse-engineering approach in an ovarian cancer model to reconstruct KRAS oncogene-dependent cytoplasmic and transcriptional networks from perturbation experiments based on gene silencing and pathway inhibitor treatments. We measured mRNA and protein levels in manipulated cells by microarray, RT-PCR and western blot analysis, respectively. The reconstructed model revealed complex interactions among the transcriptional and cytoplasmic components, some of which were confirmed by double pertubation experiments. Interestingly, the transcription factors decomposed into two hierarchically arranged groups. To validate the model predictions, we analysed growth parameters and transcriptional deregulation in the KRAS-transformed epithelial cells. As predicted by the model, we found two functional groups among the selected transcription factors. The experiments thus confirmed the predicted hierarchical transcription factor regulation and showed that the hierarchy manifests itself in downstream gene expression patterns and phenotype.

PMID:
22864383
PMCID:
PMC3421447
DOI:
10.1038/msb.2012.32
[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances

Publication type

MeSH terms

Substances

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center